Sahop, Alejandro D.

HRN: 26-43-12  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/25/2025
08/01/2025
IV
4.5g
Q6H
Sepsis, CAP-HR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaUnspecified Sepsis    Compliance to guidelines: